Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 March 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
IAC members
The IAC from left; Dr Ivor Zwane, Reneë Beck, Gus Silber, Luhlumelo Toyana, Dr Adri van der Merwe, Nick Efstathiou, Avela Ntsongelwa, Prof Colin Chasi, HOD Communication Department, Alzane Narrain, Nomvo Bam and Dr Gustav Puth.

Building ties with industry experts provides greater prospects for bursaries, prizes for top students, as well as informal internships. This is why the Department of Communication Science at the University of the Free State (UFS) took the bold and commendable step of soliciting the expertise of an Industry Advisory Council (IAC).

“As a department we believe it is important to stay in touch with the industry to ensure that we, and the work we do, stays relevant in order to increase the chances of making our students preferred candidates in the workplace,” said Dr Adri van der Merwe, lecturer at the department.

The advisory panel consisted of Reneë Beck, founder and CEO of Pink Lemon; Nick Efstathiou, newly appointed CEO of Central Media Group; DDr Ivor Zwane, chairman of the board for Small to Medium Enterprise Development; education journalist Gus Silber; journalist Alzane Narrain; Dr Gustav Puth, Academic Director of Post-Graduate Executive Education at Monash South Africa; photographer Luhlumelo Toyana; Avela Ntsongelwa,master's student and Nomvo Bam.

The initiative also created a platform for the students to engage with IAC members. The Department hosted the IAC on 6 March 2019 on the UFS Bloemfontein Campus.

Advice to assist in improving curriculum

“The IAC members’ feedback will influence our curriculum, both in the short term when we begin to shift emphasis on certain matters, as well as in the longer term when we replace or expand on specific modules,” Van der Merwe said.

The advice given by IAC members will be taken very seriously. “We have captured all their input on video, and will now, in preparation for our strategic planning session later this year, analyse and prioritise the actions we need to implement their proposals.” she said. The students are also represented on the IAC in order to hear and take into consideration what the students have to say about how the curriculum can be improved to prepare them more effectively for the workplace. 

The department plan on hosting the IAC yearly.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept